{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:02:48Z","timestamp":1794358968972,"version":"4.9.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Stafford Fox Medical Research Foundation","award":["489798"],"award-info":[{"award-number":["489798"]}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1199502"],"award-info":[{"award-number":["1199502"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008718","name":"Mason Foundation","doi-asserted-by":"crossref","award":["47107"],"award-info":[{"award-number":["47107"]}],"id":[{"id":"10.13039\/100008718","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100014834","name":"McCusker Charitable Foundation","doi-asserted-by":"crossref","award":["49979"],"award-info":[{"award-number":["49979"]}],"id":[{"id":"10.13039\/100014834","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Talei Stewart"},{"name":"Buxton Foundation","award":["4676"],"award-info":[{"award-number":["4676"]}]},{"name":"Henty Community","award":["4879"],"award-info":[{"award-number":["4879"]}]},{"name":"Blake Beckett Trust Foundation","award":["4579"],"award-info":[{"award-number":["4579"]}]},{"name":"Alison Hunter Memorial Foundation","award":["4570"],"award-info":[{"award-number":["4570"]}]},{"name":"Change for ME Charity","award":["4575"],"award-info":[{"award-number":["4575"]}]},{"name":"Dr John Hamwood"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS) and Post COVID-19 Condition (PCC) are debilitating, chronic multi-systemic illnesses that require multidisciplinary care. However, people with ME\/CFS (pwME\/CFS) and people with PCC (pwPCC) are often precluded from accessing necessary disability and social support services. These unmet care needs exacerbate the existing illness burdens experienced by pwME\/CFS and pwPCC. To deliver appropriate care and optimise health outcomes for pwME\/CFS and pwPCC, the development of evidence-based healthcare policies that recognise the disabling impacts of these illnesses must be prioritised. This systematic review summarises the health-related quality of life (HRQoL) of pwME\/CFS and pwPCC when compared with healthy controls (HCs) to elucidate the impacts of these illnesses and guide healthcare policy reform.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>CINAHL, Embase, MEDLINE, PubMed, PsycINFO and the Web of Science Core Collection were systematically searched from 1st January 2003 to 23rd July 2024. Eligible publications included observational studies capturing quantitative HRQoL data among pwME\/CFS or pwPCC when compared with HCs. The use of validated patient-reported outcome measures (PROMs) was mandatory. Eligible studies were also required to employ the most stringent diagnostic criteria currently available, including the Canadian Consensus Criteria or International Consensus Criteria for ME\/CFS and the World Health Organization case definition for PCC (PROSPERO ID: CRD42024501309).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This review captured 16 studies, including eight studies among pwME\/CFS, seven studies among pwPCC and one study among both illness cohorts. Most participants were female and middle-aged. All pwPCC had experienced prolonged COVID-19 symptoms for at least three months. When compared with HCs, all HRQoL domains were significantly impaired among pwME\/CFS and pwPCC. Both illnesses had a salient impact on physical health, including pain and ability to perform daily and work activities. While direct comparisons between pwME\/CFS and pwPCC were limited by inconsistencies in the PROMs employed, comparable impact trends across HRQoL domain scores were observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ME\/CFS and PCC have similar, profound impacts on HRQoL that warrant access to multidisciplinary disability and social support services. Future research must harmonise HRQoL data collection and prioritise longitudinal investigations among pwME\/CFS and pwPCC to characterise PCC subgroups (including those fulfilling ME\/CFS criteria) and predictors of prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-025-06131-z","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T23:52:55Z","timestamp":1741823575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Health-related quality of life in Myalgic\u00a0Encephalomyelitis\/Chronic Fatigue Syndrome and Post COVID-19 Condition: a systematic review"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8452-6656","authenticated-orcid":false,"given":"Breanna","family":"Weigel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8655-9612","authenticated-orcid":false,"given":"Maira","family":"Inderyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0815-3162","authenticated-orcid":false,"given":"Natalie","family":"Eaton-Fitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7667-770X","authenticated-orcid":false,"given":"Kiran","family":"Thapaliya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9270-2437","authenticated-orcid":false,"given":"Sonya","family":"Marshall-Gradisnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"issue":"1","key":"6131_CR1","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12967-020-02269-0","volume":"18","author":"E-J Lim","year":"2020","unstructured":"Lim E-J, Ahn Y-C, Jang E-S, Lee S-W, Lee S-H, Son C-G. Systematic review and meta-analysis of the prevalence of Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis (CFS\/ME). J Transl Med. 2020;18(1):100. https:\/\/doi.org\/10.1186\/s12967-020-02269-0.","journal-title":"J Transl Med"},{"issue":"4","key":"6131_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1365-2796.2011.02428.x","volume":"270","author":"BM Carruthers","year":"2011","unstructured":"Carruthers BM, Van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, et al. Myalgic Encephalomyelitis: International Consensus Criteria. J Intern Med. 2011;270(4):327\u201338. https:\/\/doi.org\/10.1111\/j.1365-2796.2011.02428.x.","journal-title":"J Intern Med"},{"key":"6131_CR3","unstructured":"Baraniuk JN, Marshall-Gradisnik S, Eaton-Fitch N. Myalgic Encephalomyelitis (Chronic Fatigue Syndrome). BMJ Best Practice. 2024. https:\/\/bestpractice.bmj.com\/topics\/en-us\/277. Accessed 5 Jan 2025."},{"issue":"4","key":"6131_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1515\/reveh-2015-0026","volume":"30","author":"AC Bested","year":"2015","unstructured":"Bested AC, Marshall LM. Review of Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians. Rev Environ Health. 2015;30(4):223\u201349. https:\/\/doi.org\/10.1515\/reveh-2015-0026.","journal-title":"Rev Environ Health"},{"issue":"11","key":"6131_CR5","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1016\/j.mayocp.2021.07.004","volume":"96","author":"L Bateman","year":"2021","unstructured":"Bateman L, Bested AC, Bonilla HF, Chheda BV, Chu L, Curtin JM, et al. Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: essentials of diagnosis and management. Mayo Clin Proc. 2021;96(11):2861\u201378. https:\/\/doi.org\/10.1016\/j.mayocp.2021.07.004.","journal-title":"Mayo Clin Proc"},{"key":"6131_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fped.2019.00012","volume":"7","author":"L Chu","year":"2019","unstructured":"Chu L, Valencia IJ, Garvert DW, Montoya JG. Onset patterns and course of Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. Front Pediatr. 2019;7:12. https:\/\/doi.org\/10.3389\/fped.2019.00012.","journal-title":"Front Pediatr"},{"key":"6131_CR7","unstructured":"Carruthers BM, Van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, et al. Myalgic Encephalomyelitis - Adult and paediatric: International consensus primer for medical practitioners. 2012. http:\/\/www.investinme.org\/Documents\/Guidelines\/Myalgic%20Encephalomyelitis%20International%20Consensus%20Primer%20-2012-11-26.pdf. Accessed 5 Jan 2025."},{"issue":"6611","key":"6131_CR8","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1126\/science.abo1261","volume":"377","author":"SM Marshall-Gradisnik","year":"2022","unstructured":"Marshall-Gradisnik SM, Eaton-Fitch N. Understanding Myalgic Encephalomyelitis. Science. 2022;377(6611):1150\u20131. https:\/\/doi.org\/10.1126\/science.abo1261.","journal-title":"Science"},{"issue":"9","key":"6131_CR9","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.molmed.2021.06.002","volume":"27","author":"AL Komaroff","year":"2021","unstructured":"Komaroff AL, Lipkin WI. Insights from Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome may help unravel the pathogenesis of Postacute COVID-19 Syndrome. Trends Mol Med. 2021;27(9):895\u2013906. https:\/\/doi.org\/10.1016\/j.molmed.2021.06.002.","journal-title":"Trends Mol Med"},{"key":"6131_CR10","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/s41591-022-01810-6","volume":"28","author":"J Choutka","year":"2022","unstructured":"Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. 2022;28:911\u201323. https:\/\/doi.org\/10.1038\/s41591-022-01810-6.","journal-title":"Nat Med"},{"issue":"4","key":"6131_CR11","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1177\/17423953211043106","volume":"18","author":"LA Jason","year":"2021","unstructured":"Jason LA, Yoo S, Bhatia S. Patient perceptions of infectious illnesses preceding Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. Chronic Illn. 2021;18(4):901\u201310. https:\/\/doi.org\/10.1177\/17423953211043106.","journal-title":"Chronic Illn"},{"issue":"1","key":"6131_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1477-7525-12-64","volume":"12","author":"SC Johnston","year":"2014","unstructured":"Johnston SC, Brenu EW, Hardcastle SL, Huth TK, Staines DR, Marshall-Gradisnik SM. A comparison of health status in patients meeting alternative definitions for Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis. Health Qual Life Outcomes. 2014;12(1):64. https:\/\/doi.org\/10.1186\/1477-7525-12-64.","journal-title":"Health Qual Life Outcomes"},{"issue":"9","key":"6131_CR13","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1007\/s11136-024-03710-3","volume":"33","author":"B Weigel","year":"2024","unstructured":"Weigel B, Eaton-Fitch N, Thapaliya K, Marshall-Gradisnik SM. Illness presentation and quality of life in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome and Post COVID-19 Condition: a pilot Australian cross-sectional study. Qual Life Res. 2024;33(9):2489\u2013507. https:\/\/doi.org\/10.1007\/s11136-024-03710-3.","journal-title":"Qual Life Res"},{"issue":"1","key":"6131_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/07399332.2012.684816","volume":"35","author":"VR Anderson","year":"2014","unstructured":"Anderson VR, Jason LA, Hlavaty LE. A qualitative natural history of ME\/CFS in the community. Health Care Women Int. 2014;35(1):3\u201326. https:\/\/doi.org\/10.1080\/07399332.2012.684816.","journal-title":"Health Care Women Int"},{"issue":"4","key":"6131_CR15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/03080226211020656","volume":"85","author":"C Bartlett","year":"2022","unstructured":"Bartlett C, Hughes JL, Miller L. Living with Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: experience of occupational disruption for adults in Australia. Br J Occup Ther. 2022;85(4):241\u201350. https:\/\/doi.org\/10.1177\/03080226211020656.","journal-title":"Br J Occup Ther"},{"issue":"1","key":"6131_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s10020-022-00528-y","volume":"28","author":"E Martini Sasso","year":"2022","unstructured":"Martini Sasso E, Muraki K, Eaton-Fitch N, Smith P, Lesslar OL, Deed G, et al. Transient receptor potential melastatin 3 dysfunction in Post COVID-19 Condition and Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome patients. Mol Med. 2022;28(1):98. https:\/\/doi.org\/10.1186\/s10020-022-00528-y.","journal-title":"Mol Med"},{"issue":"1","key":"6131_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12967-022-03297-8","volume":"20","author":"N Eaton-Fitch","year":"2022","unstructured":"Eaton-Fitch N, Du Preez S, Cabanas H, Muraki K, Staines DR, Marshall-Gradisnik SM. Impaired TRPM3-dependent calcium influx and restoration using naltrexone in natural killer cells of Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome patients. J Transl Med. 2022;20(1):94. https:\/\/doi.org\/10.1186\/s12967-022-03297-8.","journal-title":"J Transl Med"},{"key":"6131_CR18","doi-asserted-by":"publisher","first-page":"687806","DOI":"10.3389\/fimmu.2021.687806","volume":"12","author":"H Cabanas","year":"2021","unstructured":"Cabanas H, Muraki K, Eaton-Fitch N, Staines DR, Marshall-Gradisnik SM. Potential therapeutic benefit of low dose naltrexone in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: role of transient receptor potential melastatin 3 ion channels in pathophysiology and treatment. Front Immunol. 2021;12:687806. https:\/\/doi.org\/10.3389\/fimmu.2021.687806.","journal-title":"Front Immunol"},{"key":"6131_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jare.2021.11.013","volume":"40","author":"OA Sukocheva","year":"2022","unstructured":"Sukocheva OA, Maksoud R, Beeraka NM, Madhunapantula SV, Sinelnikov M, Nikolenko VN, et al. Analysis of Post COVID-19 Condition and its overlap with Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. J Adv Res. 2022;40:179\u201396. https:\/\/doi.org\/10.1016\/j.jare.2021.11.013.","journal-title":"J Adv Res"},{"issue":"5","key":"6131_CR20","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3390\/medicina57050418","volume":"57","author":"TL Wong","year":"2021","unstructured":"Wong TL, Weitzer DJ. Long COVID and Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS) \u2014 a systematic review and comparison of clinical presentation and symptomatology. Med Kaunas. 2021;57(5):418. https:\/\/doi.org\/10.3390\/medicina57050418.","journal-title":"Med Kaunas"},{"issue":"3","key":"6131_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis HE, McCorkell L, Moore Vogel J, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133\u201346. https:\/\/doi.org\/10.1038\/s41579-022-00846-2.","journal-title":"Nat Rev Microbiol"},{"key":"6131_CR22","unstructured":"National Institute for Health and Care Excellence, Scottish Intercollegiate Guidelines Network, Royal College of General Practitioners. COVID-19 rapid guideline: Managing the long-term effects of COVID-19. 2020. National Institute for Health and Care Excellence: England, United Kingdom. https:\/\/www.nice.org.uk\/guidance\/ng188. Accessed 5 Jan 2025."},{"key":"6131_CR23","unstructured":"Soriano JB, Allan M, Alsokhn C, Alwan NA, Askie L, Davis HE, et al. A clinical case definition of Post COVID-19 Condition by a Delphi consensus. 2021. World Health Organization: Geneva, Switzerland. https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1. Accessed 5 Jan 2025."},{"issue":"7","key":"6131_CR24","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.cmi.2022.02.018","volume":"28","author":"D Yelin","year":"2022","unstructured":"Yelin D, Moschopoulos CD, Margalit I, Gkrania-Klotsas E, Landi F, Stahl J-P, et al. ESCMID rapid guidelines for assessment and management of Long COVID. Clin Microbiol Infect. 2022;28(7):955\u201372. https:\/\/doi.org\/10.1016\/j.cmi.2022.02.018.","journal-title":"Clin Microbiol Infect"},{"key":"6131_CR25","unstructured":"Australian Institute of Health and Welfare. Long COVID in Australia \u2014 A review of the literature. 2022. Commonwealth of Australia: Canberra, Australia. https:\/\/www.aihw.gov.au\/reports\/covid-19\/long-covid-in-australia-a-review-of-the-literature\/summary. Accessed 5 Jan 2025."},{"issue":"9","key":"6131_CR26","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/infdis\/jiac136","volume":"226","author":"C Chen","year":"2022","unstructured":"Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;226(9):1593\u2013607. https:\/\/doi.org\/10.1093\/infdis\/jiac136.","journal-title":"J Infect Dis"},{"key":"6131_CR27","unstructured":"Biddle N, Korda R. The experience of COVID-19 in Australia, including Long-COVID \u2014 Evidence from the COVID-19 Impact Monitoring Survey Series, August 2022. 2022. Australian National University Centre for Social Research and Methods, National Centre for Epidemiology and Population Health: Canberra, Australia. https:\/\/csrm.cass.anu.edu.au\/sites\/default\/files\/docs\/2022\/10\/The_experience_of_COVID-19_in_Australia_-_For_web.pdf. Accessed 5 Jan 2025."},{"issue":"20","key":"6131_CR28","doi-asserted-by":"publisher","first-page":"e183810","DOI":"10.1172\/jci.insight.183810","volume":"9","author":"N Eaton-Fitch","year":"2024","unstructured":"Eaton-Fitch N, Rudd PA, Er T, Hool L, Herrero LJ, Marshall-Gradisnik SM. Immune exhaustion in ME\/CFS and Long COVID. JCI Insight. 2024;9(20):e183810. https:\/\/doi.org\/10.1172\/jci.insight.183810.","journal-title":"JCI Insight"},{"key":"6131_CR29","doi-asserted-by":"publisher","first-page":"1187163","DOI":"10.3389\/fmed.2023.1187163","volume":"10","author":"AL Komaroff","year":"2023","unstructured":"Komaroff AL, Lipkin WI. ME\/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature. Front Med. 2023;10:1187163. https:\/\/doi.org\/10.3389\/fmed.2023.1187163.","journal-title":"Front Med"},{"key":"6131_CR30","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1186\/s12967-023-04588-4","volume":"21","author":"K Taylor","year":"2023","unstructured":"Taylor K, Pearson M, Das S, Sardell J, Chocian K, Gardner S. Genetic risk factors for severe and fatigue dominant Long COVID and commonalities with ME\/CFS identified by combinatorial analysis. J Transl Med. 2023;21:775. https:\/\/doi.org\/10.1186\/s12967-023-04588-4.","journal-title":"J Transl Med"},{"issue":"1","key":"6131_CR31","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.1038\/s41467-022-32507-6","volume":"13","author":"C Kedor","year":"2022","unstructured":"Kedor C, Freitag H, Meyer-Arndt L, Wittke K, Hanitsch LG, Zoller T, et al. A prospective observational study of Post-COVID-19 Chronic Fatigue Syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat Commun. 2022;13(1):5104. https:\/\/doi.org\/10.1038\/s41467-022-32507-6.","journal-title":"Nat Commun"},{"key":"6131_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1090747","author":"H Bonilla","year":"2023","unstructured":"Bonilla H, Quach TC, Tiwari A, Bonilla AE, Miglis M, Yang PC, et al. Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): results from a post-COVID-19 multidisciplinary clinic. Front Neurol. 2023. https:\/\/doi.org\/10.3389\/fneur.2023.1090747.","journal-title":"Front Neurol"},{"key":"6131_CR33","doi-asserted-by":"publisher","first-page":"n1648","DOI":"10.1136\/bmj.n1648","volume":"374","author":"H Crook","year":"2021","unstructured":"Crook H, Raza S, Nowell J, Young M, Edison P. Long COVID\u2014mechanisms, risk factors, and management. BMJ. 2021;374:n1648. https:\/\/doi.org\/10.1136\/bmj.n1648.","journal-title":"BMJ"},{"key":"6131_CR34","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1475-9276-10-46","volume":"10","author":"JC De Carvalho Leite","year":"2011","unstructured":"De Carvalho Leite JC, De Lourdes DM, Killett A, Kale S, Nacul LC, McArthur M, et al. Social support needs for equity in health and social care: a thematic analysis of experiences of people with Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis. Int J Equity Health. 2011;10:46. https:\/\/doi.org\/10.1186\/1475-9276-10-46.","journal-title":"Int J Equity Health"},{"issue":"2","key":"6131_CR35","doi-asserted-by":"publisher","first-page":"e0281884","DOI":"10.1371\/journal.pone.0281884","volume":"18","author":"MM Hossain","year":"2023","unstructured":"Hossain MM, Das J, Rahman F, Nesa F, Hossain P, Islam AMK, et al. Living with \u201cLong COVID\u201d: a systematic review and meta-synthesis of qualitative evidence. PLoS ONE. 2023;18(2):e0281884. https:\/\/doi.org\/10.1371\/journal.pone.0281884.","journal-title":"PLoS ONE"},{"key":"6131_CR36","unstructured":"House of Representatives Standing Committee on Health, Aged Care, and Sport. Sick and tired: Casting a long shadow - Inquiry into Long COVID and Repeated COVID-19 Infections. 2023. Commonwealth of Australia: Canberra, Australia. https:\/\/parlinfo.aph.gov.au\/parlInfo\/download\/committees\/reportrep\/RB000006\/toc_pdf\/SickandtiredCastingalongshadow.pdf. Accessed 5 Jan 2025."},{"key":"6131_CR37","doi-asserted-by":"publisher","unstructured":"Weigel B, Haddock R. How patient experiences can guide the development of Long COVID health policy. 2023. Deeble Institute for Health Policy Research, Australian Healthcare and Hospitals Association: Canberra, Australia. https:\/\/doi.org\/10.25916\/b246-r560.","DOI":"10.25916\/b246-r560"},{"key":"6131_CR38","unstructured":"Reilly A, Buchanan R. ME\/CFS National Disability Agreement Review submission. 2018. https:\/\/www.pc.gov.au\/__data\/assets\/pdf_file\/0004\/230953\/sub023-disability-agreement.pdf. Accessed 5 Jan 2025."},{"issue":"1","key":"6131_CR39","doi-asserted-by":"publisher","first-page":"e13900","DOI":"10.1111\/hex.13900","volume":"27","author":"L Melby","year":"2023","unstructured":"Melby L, Das NR. \u201cWe have no services for you so you\u2026 have to make the best out of it\u201d: a qualitative study of Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome patients\u2019 dissatisfaction with healthcare services. Health Expect. 2023;27(1):e13900. https:\/\/doi.org\/10.1111\/hex.13900.","journal-title":"Health Expect"},{"issue":"1","key":"6131_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1300\/J092v11n01_02","volume":"11","author":"BM Carruthers","year":"2003","unstructured":"Carruthers BM, Jain AK, De Meirleir KL, Peterson DL, Klimas NG, Lerner AM, et al. Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. J Chronic Fatigue Syndr. 2003;11(1):7\u2013115. https:\/\/doi.org\/10.1300\/J092v11n01_02.","journal-title":"J Chronic Fatigue Syndr"},{"key":"6131_CR41","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41590-021-01104-y","volume":"23","author":"S Mehandru","year":"2022","unstructured":"Mehandru S, Merad M. Pathological sequelae of Long-Haul COVID. Nat Immunol. 2022;23:194\u2013202. https:\/\/doi.org\/10.1038\/s41590-021-01104-y.","journal-title":"Nat Immunol"},{"key":"6131_CR42","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"6131_CR43","unstructured":"Clarivate. EndNote 20. Boston, MA."},{"key":"6131_CR44","unstructured":"Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetc R, et al. Chapter 7: Systematic reviews of etiology and risk. 2024. In: Aromataris E., Lockwood C., Porritt K., Pilla B., Jordan Z. Joanna Briggs Institute. https:\/\/synthesismanual.jbi.global. Accessed 5 Jan 2025."},{"key":"6131_CR45","unstructured":"Lang TA, Altman DG. Basic statistical recording for articles published in biomedical journals: \u201cThe Statistical Analyses and Methods in the Published Literature\u201d or \u201cThe SAMPL Guidelines.\u201d 2013. In: Smart P, Maisonneuve H, Polderman A (Eds). Science Editor\u2019s Handbook, 2nd Ed. European Association of Science Editors: Cornwall, United Kingdom. https:\/\/www.equator-network.org\/wp-content\/uploads\/2013\/07\/SAMPL-Guidelines-6-27-13.pdf. Accessed 5 Jan 2025."},{"issue":"37","key":"6131_CR46","doi-asserted-by":"publisher","first-page":"E5472","DOI":"10.1073\/pnas.1607571113","volume":"113","author":"RK Naviaux","year":"2016","unstructured":"Naviaux RK, Naviaux JC, Li K, Bright AT, Alaynick WA, Wang L, et al. Metabolic features of Chronic Fatigue Syndrome. Proc Natl Acad Sci. 2016;113(37):E5472\u201380. https:\/\/doi.org\/10.1073\/pnas.1607571113.","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"6131_CR47","doi-asserted-by":"publisher","first-page":"e0198106","DOI":"10.1371\/journal.pone.0198106","volume":"13","author":"T Cambras","year":"2018","unstructured":"Cambras T, Castro-Marrero J, Zaragoza MC, D\u00edez-Noguera A, Alegre J. Circadian rhythm abnormalities and autonomic dysfunction in patients with Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis. PLoS ONE. 2018;13(6):e0198106. https:\/\/doi.org\/10.1371\/journal.pone.0198106.","journal-title":"PLoS ONE"},{"key":"6131_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare9101290","author":"C-J Chang","year":"2021","unstructured":"Chang C-J, Hung L-Y, Kogelnik AM, Kaufman D, Aiyar RS, Chu AM, et al. A comprehensive examination of severely ill ME\/CFS patients. Healthcare. 2021. https:\/\/doi.org\/10.3390\/healthcare9101290.","journal-title":"Healthcare"},{"key":"6131_CR49","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12920-017-0248-3","volume":"10","author":"WC De Vega","year":"2017","unstructured":"De Vega WC, Herrera S, Vernon SD, McGowan PO. Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS). BMC Med Genomics. 2017;10:11. https:\/\/doi.org\/10.1186\/s12920-017-0248-3.","journal-title":"BMC Med Genomics"},{"issue":"4","key":"6131_CR50","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1080\/21641846.2018.1515583","volume":"6","author":"D Maroti","year":"2018","unstructured":"Maroti D, Bileviciute-Ljungar I. Similarities and differences between health-related quality of life in patients with Exhaustion Syndrome and Chronic Fatigue Syndrome. Fatigue Biomed Health Behav. 2018;6(4):208\u201319. https:\/\/doi.org\/10.1080\/21641846.2018.1515583.","journal-title":"Fatigue Biomed Health Behav"},{"issue":"2","key":"6131_CR51","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3390\/biomedicines11020257","volume":"11","author":"VA Ryabkova","year":"2023","unstructured":"Ryabkova VA, Gavrilova NY, Poletaeva AA, Pukhalenko AI, Koshkina IA, Churilov LP, et al. Autoantibody correlation signatures in Fibromyalgia and Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: association with symptom severity. Biomedicines. 2023;11(2):257. https:\/\/doi.org\/10.3390\/biomedicines11020257.","journal-title":"Biomedicines"},{"issue":"1","key":"6131_CR52","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1515\/sjpain-2018-0095","volume":"19","author":"EB Strand","year":"2019","unstructured":"Strand EB, Marit Mengshoel A, Sandvik L, Helland IB, Abraham S, Solberg NL. Pain is associated with reduced quality of life and functional status in patients with Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. Scand J Pain. 2019;19(1):61\u201372. https:\/\/doi.org\/10.1515\/sjpain-2018-0095.","journal-title":"Scand J Pain"},{"issue":"2","key":"6131_CR53","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/acn3.51952","volume":"11","author":"M Ariza","year":"2024","unstructured":"Ariza M, Cano N, Segura B, Bejar J, Barru\u00e9 C, Bernia JA, et al. Cognitive and emotional predictors of quality of life and functioning after COVID-19. Ann Clin Transl Neurol. 2024;11(2):302\u201320. https:\/\/doi.org\/10.1002\/acn3.51952.","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"6131_CR54","doi-asserted-by":"publisher","first-page":"2220578","DOI":"10.1080\/22221751.2023.2220578","volume":"12","author":"J Cai","year":"2023","unstructured":"Cai J, Lin K, Zhang H, Xue Q, Zhu K, Yuan G, et al. A one-year follow-up study of systematic impact of Long COVID symptoms among patients post SARS-CoV-2 Omicron variants infection in Shanghai, China. Emerg Microbes Infect. 2023;12(2):2220578. https:\/\/doi.org\/10.1080\/22221751.2023.2220578.","journal-title":"Emerg Microbes Infect"},{"key":"6131_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20054049","author":"A Calvache-Mateo","year":"2023","unstructured":"Calvache-Mateo A, L\u00f3pez-L\u00f3pez L, Mart\u00edn-N\u00fa\u00f1ez J, Heredia-Ciur\u00f3 A, Granados-Santiago M, Ortiz-Rubio A, et al. Pain and clinical presentation: a cross-sectional study of patients with new-onset chronic pain in Long-COVID-19 Syndrome. Int J Environ Res Public Health. 2023. https:\/\/doi.org\/10.3390\/ijerph20054049.","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"6131_CR56","doi-asserted-by":"publisher","first-page":"e1967","DOI":"10.1002\/pri.1967","volume":"27","author":"KCA De Sousa","year":"2022","unstructured":"De Sousa KCA, Gardel DG, Lopes AJ. Postural balance and its association with functionality and quality of life in non-hospitalized patients with Post-Acute COVID-19 Syndrome. Physiother Res Int. 2022;27(4):e1967. https:\/\/doi.org\/10.1002\/pri.1967.","journal-title":"Physiother Res Int"},{"issue":"12","key":"6131_CR57","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.3390\/brainsci13121670","volume":"13","author":"K Espinar-Herranz","year":"2023","unstructured":"Espinar-Herranz K, Delgado-Lima AH, Villatoro BS, Garaboa EM, G\u00f3mez VS, Vides LG, et al. Memory, emotion, and quality of life in patients with Long COVID-19. Brain Sci. 2023;13(12):1670. https:\/\/doi.org\/10.3390\/brainsci13121670.","journal-title":"Brain Sci"},{"key":"6131_CR58","doi-asserted-by":"publisher","first-page":"14505","DOI":"10.1038\/s41598-022-18673-z","volume":"12","author":"M Nehme","year":"2022","unstructured":"Nehme M, Braillard O, Chappuis F, Guessous I. The chronification of Post-COVID Condition associated with neurocognitive symptoms, functional impairment, and increased healthcare utilization. Sci Rep. 2022;12:14505. https:\/\/doi.org\/10.1038\/s41598-022-18673-z.","journal-title":"Sci Rep"},{"key":"6131_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2023.06.010","author":"M-C Seeley","year":"2023","unstructured":"Seeley M-C, Gallagher C, Ong E, Langdon A, Chieng J, Bailey D, et al. High incidence of autonomic dysfunction and postural orthostatic tachycardia syndrome in patients with Long COVID: implications for management and health care planning. Am J Med. 2023. https:\/\/doi.org\/10.1016\/j.amjmed.2023.06.010.","journal-title":"Am J Med"},{"key":"6131_CR60","volume-title":"The clinical evaluation of chemotherapeutic agents in cancer","author":"DA Karnofsky","year":"1949","unstructured":"Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. New York: Columbia University Press; 1949."},{"issue":"7","key":"6131_CR61","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1001\/jama.1989.03430070073033","volume":"262","author":"AR Tarlov","year":"1989","unstructured":"Tarlov AR, Ware JE Jr, Greenfield S, Nelson EC, Perrin E, Zubkoff M. The Medical Outcomes Study \u2014 an application of methods for monitoring the results of medical care. JAMA. 1989;262(7):925\u201330. https:\/\/doi.org\/10.1001\/jama.1989.03430070073033.","journal-title":"JAMA"},{"key":"6131_CR62","unstructured":"EuroQoL Research Foundation. EQ-5D-3L user guide (version 6.0). 2018 https:\/\/euroqol.org\/wp-content\/uploads\/2023\/11\/EQ-5D-3LUserguide-23-07.pdf. Accessed 5 Jan 2025."},{"key":"6131_CR63","unstructured":"EuroQoL Research Foundation. EQ-5D-5L user guide (version 3.0). 2019 https:\/\/euroqol.org\/wp-content\/uploads\/2023\/11\/EQ-5D-5LUserguide-23-07.pdf. Accessed 5 Jan 2025."},{"key":"6131_CR64","unstructured":"Bell DS. The doctor\u2019s guide to Chronic Fatigue Syndrome: Understanding, treating, and living with CFIDS. 1995."},{"key":"6131_CR65","unstructured":"Sheehan DV. The Sheehan Disability Scales. 1983."},{"key":"6131_CR66","unstructured":"\u00dcst\u00fcn TB, Kostanjsek N, Chatterji S, Rehm J, World Health Organization. Measuring health and disability: Manual for WHO Disability Assessment Schedule (WHODAS 2.0). 2010. World Health Organization: Geneva, Switzerland. https:\/\/www.who.int\/publications\/i\/item\/measuring-health-and-disability-manual-for-who-disability-assessment-schedule-(-whodas-2.0). Accessed 5 Jan 2025."},{"key":"6131_CR67","unstructured":"Division of Mental Health and Prevention of Substance Abuse, World Health Organization. WHOQOL user manual. 2012. World Health Organization: Geneva, Switzerland. https:\/\/iris.who.int\/bitstream\/handle\/10665\/77932\/WHO_HIS_HSI_Rev.2012.03_eng.pdf?sequence=1. Accessed 5 Jan 2025."},{"issue":"1","key":"6131_CR68","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12888-022-04497-8","volume":"23","author":"M Samper-Pardo","year":"2023","unstructured":"Samper-Pardo M, Oliv\u00e1n-Bl\u00e1zquez B, Magall\u00f3n-Botaya R, M\u00e9ndez-L\u00f3pez F, Bartolom\u00e9-Moreno C, Le\u00f3n-Herrera S. The emotional well-being of Long COVID patients in relation to their symptoms, social support and stigmatization in social and health services: a qualitative study. BMC Psychiatry. 2023;23(1):68. https:\/\/doi.org\/10.1186\/s12888-022-04497-8.","journal-title":"BMC Psychiatry"},{"key":"6131_CR69","doi-asserted-by":"publisher","first-page":"113369","DOI":"10.1016\/j.socscimed.2020.113369","volume":"265","author":"K Pilkington","year":"2020","unstructured":"Pilkington K, Ridge DT, Igwesi-Chidobe CN, Chew-Graham CA, Little P, Babatunde O, et al. A relational analysis of an invisible illness: a meta-ethnography of people with Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis (CFS\/ME) and their support needs. Soc Sci Med. 2020;265:113369. https:\/\/doi.org\/10.1016\/j.socscimed.2020.113369.","journal-title":"Soc Sci Med"},{"key":"6131_CR70","doi-asserted-by":"publisher","first-page":"e068481","DOI":"10.1136\/bmjopen-2022-068481","volume":"13","author":"C Thomas","year":"2023","unstructured":"Thomas C, Faghy MA, Owen R, Yates J, Ferraro F, Bewick T, et al. Lived experience of patients with Long COVID: a qualitative study in the UK. BMJ Open. 2023;13:e068481. https:\/\/doi.org\/10.1136\/bmjopen-2022-068481.","journal-title":"BMJ Open"},{"issue":"7","key":"6131_CR71","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3109\/09638288.2010.503256","volume":"33","author":"LA Jason","year":"2011","unstructured":"Jason LA, Brown M, Evans M, Anderson VR, Lerch A, Brown A, et al. Measuring substantial reduction in functioning in patients with CFS. Disabil Rehabil. 2011;33(7):589\u201398. https:\/\/doi.org\/10.3109\/09638288.2010.503256.","journal-title":"Disabil Rehabil"},{"key":"6131_CR72","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3389\/fneur.2020.01025","volume":"11","author":"B Stussman","year":"2020","unstructured":"Stussman B, Williams A, Snow J, Gavin A, Scott R, Nath A, et al. Characterization of post-exertional malaise in patients with Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. Front Neurol. 2020;11:1025. https:\/\/doi.org\/10.3389\/fneur.2020.01025.","journal-title":"Front Neurol"},{"key":"6131_CR73","unstructured":"Friedberg F, Bateman L, Bested AC, Davenport T, Friedman KJ, Gurwitt A, et al. Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis - Primer for clinical practitioners. 2014 Edition. International Association of Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis. 2014. https:\/\/massmecfs.org\/images\/pdf\/Primer_2014.pdf. Accessed 5 Jan 2025."},{"issue":"3","key":"6131_CR74","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.dsx.2021.04.007","volume":"15","author":"AV Raveendran","year":"2021","unstructured":"Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: an overview. Diabetes Metab Syndr Clin Res Rev. 2021;15(3):869\u201375. https:\/\/doi.org\/10.1016\/j.dsx.2021.04.007.","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"6131_CR75","doi-asserted-by":"publisher","first-page":"e077886","DOI":"10.1136\/bmjopen-2023-077886","volume":"14","author":"J Yang","year":"2024","unstructured":"Yang J, Markus K, Andersen KM, Rudolph AE, McGrath LJ, Nguyen JL, et al. Definition and measurement of Post-COVID-19 Conditions in real-world practice: a global systematic literature review. BMJ Open. 2024;14:e077886. https:\/\/doi.org\/10.1136\/bmjopen-2023-077886.","journal-title":"BMJ Open"},{"issue":"1","key":"6131_CR76","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1741-7015-3-19","volume":"3","author":"WC Reeves","year":"2005","unstructured":"Reeves WC, Wagner D, Nisenbaum R, Jones JF, Gurbaxani B, Solomon L, et al. Chronic Fatigue Syndrome \u2014 a clinically empirical approach to its definition and study. BMC Med. 2005;3(1):19. https:\/\/doi.org\/10.1186\/1741-7015-3-19.","journal-title":"BMC Med"},{"issue":"2","key":"6131_CR77","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3844\/ajbbsp.2010.120.135","volume":"6","author":"LA Jason","year":"2010","unstructured":"Jason LA, Evans M, Porter N, Brown M, Brown A, Hunnell J, et al. The development of a revised Canadian Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome case definition. Am J Biochem Biotechnol. 2010;6(2):120\u201335. https:\/\/doi.org\/10.3844\/ajbbsp.2010.120.135.","journal-title":"Am J Biochem Biotechnol"},{"issue":"8","key":"6131_CR78","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/ofid\/ofac397","volume":"9","author":"A Fischer","year":"2022","unstructured":"Fischer A, Zhang L, Elb\u00e9ji A, Wilmes P, Oustric P, Staub T, et al. Long COVID symptomatology after 12 months and its impact on quality of life according to initial coronavirus disease 2019 disease severity. Open Forum Infect Dis. 2022;9(8):397. https:\/\/doi.org\/10.1093\/ofid\/ofac397.","journal-title":"Open Forum Infect Dis"},{"key":"6131_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00826","author":"L Nacul","year":"2020","unstructured":"Nacul L, O\u2019Boyle S, Palla L, Nacul FE, Mudie K, Kingdon CC, et al. How Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS) progresses: the natural history of ME\/CFS. Front Neurol. 2020. https:\/\/doi.org\/10.3389\/fneur.2020.00826.","journal-title":"Front Neurol"},{"key":"6131_CR80","doi-asserted-by":"publisher","first-page":"102146","DOI":"10.1016\/j.eclinm.2023.102146","volume":"63","author":"F Legler","year":"2023","unstructured":"Legler F, Meyer-Arndt L, M\u00f6dl L, Kedor C, Freitag H, Stein E, et al. Long-term symptom severity and clinical biomarkers in Post-COVID-19\/Chronic Fatigue Syndrome: results from a prospective observational cohort. eClinicalMedicine. 2023;63:102146. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102146.","journal-title":"eClinicalMedicine"},{"key":"6131_CR81","doi-asserted-by":"publisher","first-page":"101019","DOI":"10.1016\/j.eclinm.2021.101019","volume":"38","author":"HE Davis","year":"2021","unstructured":"Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re\u2019em Y, et al. Characterising Long COVID in an international cohort: 7 months of symptoms and their impact. Lancet Discov Sci. 2021;38:101019. https:\/\/doi.org\/10.1016\/j.eclinm.2021.101019.","journal-title":"Lancet Discov Sci"},{"key":"6131_CR82","doi-asserted-by":"publisher","first-page":"1604501","DOI":"10.3389\/phrs.2022.1604501","volume":"43","author":"V Nittas","year":"2022","unstructured":"Nittas V, Gao M, West EA, Ballouz T, Menges D, Wulf Hanson S, et al. Long COVID through a public health lens: an umbrella review. Public Health Rev. 2022;43:1604501. https:\/\/doi.org\/10.3389\/phrs.2022.1604501.","journal-title":"Public Health Rev"},{"key":"6131_CR83","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1186\/s12889-019-7225-z","volume":"19","author":"J Castro-Marrero","year":"2019","unstructured":"Castro-Marrero J, Faro M, Cleof\u00e9 Zaragoz\u00e1 M, Aliste L, de Fern\u00e1ndez Sevilla T, Alegre J. Unemployment and work disability in individuals with Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis: a community-based cross-sectional study from Spain. BMC Public Health. 2019;19:940. https:\/\/doi.org\/10.1186\/s12889-019-7225-z.","journal-title":"BMC Public Health"},{"issue":"6","key":"6131_CR84","doi-asserted-by":"publisher","first-page":"e069217","DOI":"10.1136\/bmjopen-2022-069217","volume":"13","author":"S Walker","year":"2023","unstructured":"Walker S, Goodfellow H, Pookarnjanamorakot P, Murray E, Bindman J, Blandford A, et al. Impact of fatigue as the primary determinant of functional limitations among patients with Post-COVID-19 Syndrome: a cross-sectional observational study. BMJ Open. 2023;13(6):e069217. https:\/\/doi.org\/10.1136\/bmjopen-2022-069217.","journal-title":"BMJ Open"},{"key":"6131_CR85","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1002\/nbm.1692","volume":"24","author":"LR Barnden","year":"2011","unstructured":"Barnden LR, Crouch B, Kwiatek R, Burnet R, Mernone A, Chryssidis S, et al. A brain MRI study of Chronic Fatigue Syndrome: evidence of brainstem dysfunction and altered homeostasis. Nucl Magn Reson Biomed. 2011;24:1302\u201312. https:\/\/doi.org\/10.1002\/nbm.1692.","journal-title":"Nucl Magn Reson Biomed"},{"issue":"5","key":"6131_CR86","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1002\/jmri.25283","volume":"44","author":"ZY Shan","year":"2016","unstructured":"Shan ZY, Kwiatek R, Burnet R, Del Fante P, Staines DR, Marshall-Gradisnik SM, et al. Progressive brain changes in patients with Chronic Fatigue Syndrome: a longitudinal MRI study. J Magn Reson Imaging. 2016;44(5):1301\u201311. https:\/\/doi.org\/10.1002\/jmri.25283.","journal-title":"J Magn Reson Imaging"},{"key":"6131_CR87","unstructured":"World Health Organization. Version Espa\u00f1ola del WHOQOL-BREF. 2020. World Health Organization: Geneva, Switzerland. https:\/\/www.who.int\/tools\/whoqol\/whoqol-bref\/docs\/default-source\/publishing-policies\/whoqol-bref\/spanish-spain-whoqol-bref. Accessed 5 Jan 2025."},{"issue":"20","key":"6131_CR88","first-page":"771","volume":"104","author":"J Alonso","year":"1995","unstructured":"Alonso J, Prieto L, Ant\u00f3 JM. The Spanish version of the SF-36 health survey (the SF-36 health questionnaire): an instrument for measuring clinical results. Med Clin Barc. 1995;104(20):771\u20136.","journal-title":"Med Clin Barc"},{"issue":"3","key":"6131_CR89","first-page":"143","volume":"39","author":"RM Ciconelli","year":"1999","unstructured":"Ciconelli RM, Ferraz MB, Santos W, Minhoto Meinao I, Rodrigues QM. Brazilian-Portuguese version of the SF-36. A reliable and valid quality of life outcome measure. Rev Bras Reumatol. 1999;39(3):143\u201350.","journal-title":"Rev Bras Reumatol"},{"issue":"3","key":"6131_CR90","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/hec.4730020305","volume":"2","author":"RD Hays","year":"1993","unstructured":"Hays RD, Donald Sherbourne C, Mazel RM. The RAND 36-item health survey 1.0. Health Econ. 1993;2(3):217\u201327. https:\/\/doi.org\/10.1002\/hec.4730020305.","journal-title":"Health Econ"},{"issue":"11","key":"6131_CR91","first-page":"410","volume":"111","author":"J Alonso","year":"1998","unstructured":"Alonso J, Regidor E, Barrio G, Prieto L, Rodr\u00edguez C, De la Fuente L. Population reference values of the Spanish version of the health questionnaire SF-36. Med Clin Barc. 1998;111(11):410\u20136.","journal-title":"Med Clin Barc"},{"issue":"6","key":"6131_CR92","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Donald SC. The MOS 36-item short-form health survey (SF-36). Med Care. 1992;30(6):473\u201383.","journal-title":"Med Care"},{"issue":"11","key":"6131_CR93","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/S0895-4356(98)00102-4","volume":"51","author":"M Sullivan","year":"1998","unstructured":"Sullivan M, Karlsson J. The Swedish SF-36 health survey III. Evaluation of criterion-based validity: results from normative population. J Clin Epidemiol. 1998;51(11):1105\u201313. https:\/\/doi.org\/10.1016\/S0895-4356(98)00102-4.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"6131_CR94","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"JE Ware Jr","year":"1996","unstructured":"Ware JE Jr, Kosinski M, Keller S. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220\u201333. https:\/\/doi.org\/10.1097\/00005650-199603000-00003.","journal-title":"Med Care"},{"issue":"24","key":"6131_CR95","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1097\/00007632-200012150-00008","volume":"25","author":"JE Ware Jr","year":"2000","unstructured":"Ware JE Jr. SF-36 health survey update. Spine. 2000;25(24):3130\u20139. https:\/\/doi.org\/10.1097\/00007632-200012150-00008.","journal-title":"Spine"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06131-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06131-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06131-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T23:53:27Z","timestamp":1741823607000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06131-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6131"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06131-z","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"8 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As the present study is a systematic review of existing literature, neither ethical approval nor consent to participate was required. However, the present study included the acquisition of ethical approval and ascertainment of informed consent prior to participation as a requirement for inclusion in the review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"318"}}